跳至主要内容
临床试验/NCT05970770
NCT05970770尚未招募4 期

Hypotension Prediction Index Therapy is Non-inferior to Continuous Norepinephrine Infusion for Fetal Wellbeing in the Prevention of Spinal Anesthesia-Induced Hypotension for Cesarean Delivery: a Randomized Controlled Trial

Fondazione Policlinico Universitario Agostino Gemelli IRCCS0 个研究点目标入组 150 人开始时间: 2023年9月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
尚未招募
入组人数
150
主要终点
Fetal Base excess

研究概览

简要总结

The goal of this randomized controlled trial is to compare for non inferiority for fetal wellbeing Hypotension Prediction Index - Guided Therapy and Continuous Norepinephrine Infusion in in the Prevention of Spinal Anesthesia-Induced Hypotension for Cesarean Delivery.

The main question it aims to answer are:

• are fetal arterial base excess comparable with the two treatments?

Participants will undergo continuous noninvasive hemodynamic monitoring with advanced Hypotension Prediction Index Researchers will compare with patients receiving continuous norepinephrine infusion and standard blood pressure monitoring with arm cuff.

详细描述

In the Hypotension Prediction Index group, patients will be monitored continuously with a noninvasive hemodynamic device. The Hypotension Prediction Index is a number based on al algorithm that predicts impeding hypotension if it is greater than 85. In the treatment group, patients will be treated with norepinephrine boluses if the Hypotension Prediction Index is >85. In the control group patients will be treated with preventive continuous infusion of norepinephrine and blood pressure will be measured noninvasively every minute. Data about blood pressure and the vasopressive treatment will start concomitantly to the administration of spinal anesthesia and will stop after delivery. blood gas samples will be then collected from the placental umbilical artery to compare fetal arterial base excess as primary outcome for non-inferiority.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Pregnant women between the 36th and the 40th week of gestation undergoing spinal anesthesia for elective caesarian delivery.

排除标准

  • preeclampsia;
  • eclampsia;
  • atrial fibrillation and sinus tachycardia;
  • cardiovascular diseases;
  • neuromuscular disease;
  • emergent or urgent cesarean delivery;
  • coagulopathies;
  • contraindications to spinal anesthesia.

研究组 & 干预措施

Hypotension Prediction Index

Experimental

Patients will be monitored with Hypotension Prediction Index which will guide vasopressor therapy with boluses of norepinephrine

干预措施: Hypotension Prediction Index (Device)

Hypotension Prediction Index

Experimental

Patients will be monitored with Hypotension Prediction Index which will guide vasopressor therapy with boluses of norepinephrine

干预措施: Norepinephrine (Drug)

Non Invasive Blood Pressure

Active Comparator

Spinal-induced hypotension will be prevented by continuous preventive norepinephrine infusion and blood pressure will be monitored by non invasive arm cuff every minute

干预措施: Norepinephrine (Drug)

结局指标

主要结局

Fetal Base excess

时间窗: at birth

withdrawn from umbilical fetal artery as index of perioperative metabolic acidosis

次要结局

  • Hypertensive episodes(from spinal anesthesia until delivery)
  • Apgar score(at 5 minutes from birth)
  • Hypotensive episodes(from spinal anesthesia until delivery)
  • Total vasopressor dose(from spinal anesthesia until delivery)
  • Fetal arterial pH(at birth)

研究者

申办方类型
Other
责任方
Sponsor

相似试验